Insights

AmerisourceBergen

Financial Management for Cell and Gene Therapies

Albert Cooksey

ICS

Update on the DSCSA Product Serialization November 2017 Mandate

Terrence Jones

ICS

Transitioning 3PL Partners

ICS

Commercializing Cell and Gene Therapies

Researcher examines test tube

ICS

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Associate picking at Louisville Distribution Center

ICS

Meet the Experts ISO 9001:2015

ICS

Solving Challenges with Third-Party Logistics

ICS

Meet the Experts: Serializing Your Products

ICS

ISO 9001:2015 What the New Standard Means for Pharmaceutical Manufacturers

Associates viewing a presentation while meeting in a conference room

ICS

Serializing Your Products

ICS

Three Ways Title Model Powers Pharma Innovation

ICS

Life-changing Launch

ICS

Connecting The Data Dots

ICS

Are You Prepared for DSCSA?

ICS

One Nation, Under DSCSA

Racking infrastructure of our Louisville Distribution Center

ICS

Making a Case for Title Model

Two associates work together while writing on a whiteboard

ICS

Can Your 3PL Partner Grow with You - Part 5

ICS

Can Your 3PL Partner Grow with You - Part 4

ICS

Can Your 3PL Partner Grow with You - Part 3

ICS

Three Critical Components of the Specialty 3PL Experience

ICS

Executive Q&A: Broadening the Scope of 3PL

ICS

Can Your 3PL Partner Grow with You - Part 2

ICS

Can Your 3PL Partner Grow with You - Part 1

ICS

Driving New Value from 3PL Data Part 2

ICS

Driving New Value from 3PL Data Part 1

ICS

Specialty 3PL & the Client Experience Pt. 2

ICS

Specialty 3PL & the Client Experience Pt. 1

ICS

Executive Q & A: Models Matter

ICS

The New Four Ps of Cold Chain Management

ICS

Drug Quality and Security Act Podcast Part 2

ICS

Partnering for Packaging

ICS

The Specifics of ISO 9000

ICS

Drug Quality and Security Act Podcast Part 1

ICS

Why ISO 9000 Certification Matters to Manufacturers

ICS

Understanding ISO 9000 Certification

ICS

ISO 9000 Certification